Illness	Number of cases
Hyperplasia of prostate (N40)	516
Malignant neoplasm of prostate (C61)	369
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	224
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	220
Calculus of kidney and ureter - Calculus of kidney (N20.0)	208
Calculus of kidney and ureter - Calculus of ureter (N20.1)	176
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	115
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2)	88
Cystitis (N30.2)	82
Other disorders of bladder (N32.8)	80

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	1.276
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0)	603
Insertion, exchange or removal of a ureteral stent (8-137.10)	570
Operation using a surgical robot (5-987.0)	386
Examination of the urethra and the urinary bladder by endoscopy (1-661)	340
Insertion, exchange or removal of a ureteral stent (8-137.00)	337
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.41)	288
Surgical incision into the ureter or removal of a stone during an open operation or endoscopy (5-562.8)	284
Treatment procedures requiring dyes (5-989)	244
Surgical incision into the ureter or removal of a stone during an open operation or endoscopy (5-562.4)	217

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	0

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
49	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
8	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
7	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Student training (clinical traineeship / internship year)
Participation in multi-centre Phase I/II studies
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Editors of scientific journals/textbooks
Doctoral supervision
Lectureships / teaching posts at colleges and universities